Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new software revision tag (v3.6.4) replaces the previous tag (v3.6.3) in the study record history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.6.3 was added to the history, replacing the previous v3.6.2. This reflects an updated page revision in the study record.SummaryDifference0.1%

- Check43 days agoChange DetectedThe Record History now shows the latest revision as v3.6.2 and removes the previous v3.6.0 entry, updating the page's version label.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study history now includes a new revision labeled v3.6.0 with the recruitment status updated to not currently recruiting participants. The previous revision entry v3.5.5 appears to have been removed from the history.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page history shows a newer revision version, updating from v3.5.4 to v3.5.5, indicating a small metadata update to the page history rather than a change to core study information.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page revision label was updated to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.